The Resource Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan

Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan

Label
Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan
Title
Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan
Creator
Subject
Language
eng
Summary
The authors analyse the impact of specific Mexican requirements on the transfer pricing structure and intercompany transactions in the pharmaceutical industry in light of Action 8 of the Action Plan on Base Erosion and Profit Shifting (BEPS)
Citation source
In: International transfer pricing journal. - Amsterdam. - Vol. 22 (2015),
http://library.link/vocab/creatorName
  • Milewska, M
  • Amaya, E
Geographic coverage
  • Central America
  • Latin America
Language note
English
http://library.link/vocab/subjectName
  • transfer pricing
  • pharmaceutical industry
  • BEPS Project (OECD)
  • patent
Label
Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan
Instantiates
Publication
Label
Transfer pricing implications of second-brand strategies in the pharmaceutical industry in light of the OECD report on Action 8 of the BEPS Action Plan
Publication

Library Locations

    • IBFD Library AmsterdamBorrow it
      Rietlandpark 301, Amsterdam, 1019 DW, NL
      52.3736660 4.9336932
Processing Feedback ...